Skip to main content

Peer Review reports

From: Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations

Original Submission
6 Sep 2022 Submitted Original manuscript
11 Oct 2022 Reviewed Reviewer Report
5 Nov 2022 Reviewed Reviewer Report
17 Nov 2022 Author responded Author comments - Hua Yuan
Resubmission - Version 2
17 Nov 2022 Submitted Manuscript version 2
22 Nov 2022 Author responded Author comments - Hua Yuan
Resubmission - Version 3
22 Nov 2022 Submitted Manuscript version 3
24 Nov 2022 Author responded Author comments - Hua Yuan
Resubmission - Version 4
24 Nov 2022 Submitted Manuscript version 4
29 Nov 2022 Reviewed Reviewer Report
9 Dec 2022 Reviewed Reviewer Report
12 Dec 2022 Author responded Author comments - Hua Yuan
Resubmission - Version 5
12 Dec 2022 Submitted Manuscript version 5
15 Dec 2022 Author responded Author comments - Hua Yuan
Resubmission - Version 6
15 Dec 2022 Submitted Manuscript version 6
Publishing
16 Dec 2022 Editorially accepted
21 Dec 2022 Article published 10.1186/s12885-022-10456-z

You can find further information about peer review here.

Back to article page